Report cover image

Global & India Cancer Therapeutics Market to 2031

Publisher Business Market Insights
Published Jun 04, 2025
Length 100 Pages
SKU # BMKS20063459

Description

India has experienced a marked increase in cancer cases over recent years, highlighting the urgent need for advanced treatment options. According to GLOBOCAN 2020 data, the country reported approximately 1.3 million new cancer diagnoses. Breast cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk rate of 2.81.

The growing demand for effective therapies has led to a wave of new product launches in India, particularly targeting breast cancer through genomic techniques, targeted therapies, and immunotherapies. These developments have not only improved treatment outcomes but have also opened up new opportunities for pharmaceutical companies to expand their oncology portfolios. For example, in January 2023, a wholly owned subsidiary of Sun Pharmaceutical Industries Limited launched Palbociclib, a next-generation cancer treatment, for patients with advanced breast cancer—the most commonly diagnosed cancer among Indian women.

In January 2024, AstraZeneca India Pharma Ltd., in collaboration with Daiichi Sankyo, introduced trastuzumab deruxtecan, a HER2-targeted antibody-drug conjugate designed for adult patients with unresectable or metastatic HER2-positive breast cancer who have already undergone prior anti-HER2 therapy. Additionally, in November 2024, Dr. Reddy’s Laboratories launched toripalimab, an immuno-oncology drug approved by major regulatory agencies including the USFDA, EMA, and MHRA, for treating adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). These new therapies are playing a crucial role in addressing the treatment gap in India’s cancer care landscape and are contributing significantly to the growth of the cancer therapeutics market in the country.

Table of Contents

100 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. India Cancer Therapeutics Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Cancer Therapeutics Market Key Market Dynamics
5.1 Cancer Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. India Cancer Therapeutics Market – Analysis
6.1 India Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
6.2 India Cancer Therapeutics Market Revenue and Forecast Analysis
7. India Cancer Therapeutics Market Analysis – by Therapy Types
7.1 India Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
8. India Cancer Therapeutics Market Analysis – by Indications
8.1 India Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
9. India Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 India Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Bristol-Myers Squibb Co
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 AbbVie Inc
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Johnson & Johnson
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Pfizer Inc
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 AstraZeneca Plc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Merck KGaA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Novartis AG
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Astellas Pharma Inc
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Eli Lilly and Co
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. India Cancer Therapeutics Market Segmentation
Table 2. List of Vendors
Table 3. India Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
Table 4. India Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. India Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
Table 6. India Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
Table 7. India Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 8. India Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 9. India Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
Table 10. India Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. India Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us